Trial of Regeneron’s Covid-19 Antibody Drug Is Halted in Sickest Hospital Patients - The Wall Street Journal
- Trial of Regeneron’s Covid-19 Antibody Drug Is Halted in Sickest Hospital Patients The Wall Street Journal
- Regeneron hit by 'safety signal' for COVID-19 cocktail as data board tells pharma to stop enrolling sicker patients FierceBiotech
- Regeneron says IDMC recommends halt of some REGN-COV2 trial enrollment for safety risks MarketWatch
- 2nd study testing a COVID-19 antibody drug has a setback ABC News
- Regeneron suspends COVID-19 antibody trial among sickest patients Medical Xpress
- View Full Coverage on Google News